https://www.wto.org/english/tratop_e/trips_e/wto_background_e.pdf

It provides information on assessing the extent to which differential pricing of essential drugs can assist in balancing the need to make existing drugs affordable to those who need them in poorer countries with preserving the incentives for inventing and developing new and better treatments provided for in the TRIPS Agreement.